Literature DB >> 21321308

microRNAs in hypertrophy and heart failure.

Michael V G Latronico1, Gianluigi Condorelli.   

Abstract

microRNAs (miRNAs) are highly conserved, short non-coding RNAs that have become established as having an important role in regulatory networks. We review here the progress made in our understanding of heart-related microRNAs over the last two years, focusing mainly on hypertrophic growth and heart failure.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21321308     DOI： 10.1258/ebm.2010.010269

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


  19 in total

Review 1.  Therapeutic use of microRNAs in myocardial diseases.

Authors:  Michael V G Latronico; Gianlugi Condorelli
Journal:  Curr Heart Fail Rep       Date:  2011-09

Review 2.  Novel putative pharmacological therapies to protect the right ventricle in pulmonary hypertension: a review of current literature.

Authors:  Gerald J Maarman; Rainer Schulz; Karen Sliwa; Ralph Theo Schermuly; Sandrine Lecour
Journal:  Br J Pharmacol       Date:  2017-02-24       Impact factor: 8.739

Review 3.  HypoxamiR regulation and function in ischemic cardiovascular diseases.

Authors:  Simona Greco; Carlo Gaetano; Fabio Martelli
Journal:  Antioxid Redox Signal       Date:  2013-11-12       Impact factor: 8.401

4.  Defining miRNA targets: balancing simplicity with complexity.

Authors:  Jane E Freedman; Kahraman Tanriverdi
Journal:  Circulation       Date:  2013-04-26       Impact factor: 29.690

5.  Distinct microRNA expression signatures in human right atrial and ventricular myocardium.

Authors:  Yangyang Zhang; Xiaowei Wang; Xiaohan Xu; Jun Wang; Xiang Liu; Yijiang Chen
Journal:  Mol Cell Biochem       Date:  2012-08-14       Impact factor: 3.396

6.  Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.

Authors:  Kun Wang; Zhi-Qiang Lin; Bo Long; Jian-Hui Li; Jing Zhou; Pei-Feng Li
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 7.  Neurogenic hypertension: revelations from genome-wide gene expression profiling.

Authors:  Francine Z Marques; Brian J Morris
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 8.  In search of new therapeutic targets and strategies for heart failure: recent advances in basic science.

Authors:  Ajay M Shah; Douglas L Mann
Journal:  Lancet       Date:  2011-08-20       Impact factor: 79.321

9.  MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex.

Authors:  Andriy E Belevych; Sarah E Sansom; Radmila Terentyeva; Hsiang-Ting Ho; Yoshinori Nishijima; Mickey M Martin; Hitesh K Jindal; Jennifer A Rochira; Yukiko Kunitomo; Maha Abdellatif; Cynthia A Carnes; Terry S Elton; Sandor Györke; Dmitry Terentyev
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

10.  Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions.

Authors:  Caterina Vacchi-Suzzi; Florian Hahne; Philippe Scheubel; Magali Marcellin; Valerie Dubost; Magdalena Westphal; Catherine Boeglen; Stine Büchmann-Møller; Ming Sin Cheung; André Cordier; Christopher De Benedetto; Mark Deurinck; Moritz Frei; Pierre Moulin; Edward Oakeley; Olivier Grenet; Armelle Grevot; Robert Stull; Diethilde Theil; Jonathan G Moggs; Estelle Marrer; Philippe Couttet
Journal:  PLoS One       Date:  2013-01-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.